Mukilteo, WA, United States of America

Douglas C Covert

This inventor holds 2 USPTO granted patents. Top assignee: Zymogenetics, Inc.. Active years: 2007-2010.


% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Douglas C. Covert

Introduction

Douglas C. Covert is an accomplished inventor based in Mukilteo, WA (US). He has made significant contributions to the field of biotechnology, particularly in the production of interleukin-21 (IL-21). With a total of 2 patents, his work has advanced the methods of protein production in prokaryotic hosts.

Latest Patents

Covert's latest patents focus on the large-scale production of IL-21 using expression vectors. These vectors are designed with specific nucleotide changes to optimize codons and mRNA secondary structures for enhanced translation efficiency. His innovative approach has led to the successful production of the IL-21 gene at levels exceeding 1 g/L in fed-batch fermentation. Additionally, his patents include OmpT deficient strains transformed with an IL-21 expression vector, further showcasing his expertise in this area.

Career Highlights

Douglas C. Covert has been instrumental in his role at Zymogenetics, Inc., where he has applied his knowledge and skills to develop cutting-edge biotechnological solutions. His work has not only contributed to the scientific community but has also paved the way for advancements in therapeutic applications.

Collaborations

Covert has collaborated with notable colleagues such as Bruce L. Zamost and Hong Yan Liu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Douglas C. Covert's contributions to biotechnology, particularly in the production of IL-21, highlight his role as a leading inventor in the field. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving biotechnological processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…